dr. böhm sunatoare 425 mg
apomedica pharmazeutische produkte gmbh - austria - plante (sunatoare) - caps. - 425mg - antidepresive antidepresive
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
medabon (vezi g03xb01)
sun pharmaceutical industries europe b.v. - olanda - combinatii (mifepristonum+misoprostolum) - compr.+compr. vag. - 200mg+0,2mg - ocitocice prostaglandine
sunitinib teva 12,5 mg
teva operations poland sp. z.o.o - polonia - sunitinibum - caps. - 12,5mg - inhibitori de protein-kinaza
sunitinib teva 25 mg
teva operations poland sp. z.o.o - polonia - sunitinibum - caps. - 25mg - inhibitori de protein-kinaza
sunitinib teva 50 mg
teva operations poland sp. z.o.o - polonia - sunitinibum - caps. - 50mg - inhibitori de protein-kinaza
sunitinib alvogen 12,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 12,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 25 mg
remedica ltd. - cipru - sunitinibum - caps. - 25mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 37,5 mg
remedica ltd. - cipru - sunitinibum - caps. - 37,5mg - alte antineoplazice inhibitori de protein-kinaza
sunitinib alvogen 50 mg
remedica ltd. - cipru - sunitinibum - caps. - 50mg - alte antineoplazice inhibitori de protein-kinaza